NRX Pharma Execs Bet Big on Ketamine Breakthrough, Swiping RSUs Amid Volatile Shares
Insider buying spikes NRX stock confidence as executives bet on FDA‑approved ketamine and future growth—what to watch for investors.
3 minutes to read
NRX PHARMACEUTICALS INC